Cite
HARVARD Citation
Tateishi, K. et al. (2019). CpG ODN G9.1 as a novel nasal ODN adjuvant elicits complete protection from influenza virus infection without causing inflammatory immune responses. Vaccine. 37 (36), pp. 5382-5389. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tateishi, K. et al. (2019). CpG ODN G9.1 as a novel nasal ODN adjuvant elicits complete protection from influenza virus infection without causing inflammatory immune responses. Vaccine. 37 (36), pp. 5382-5389. [Online].